Abstract:BACKGROUND:Cutaneous squamous cell carcinoma (CSCC) is the second most widespread cancer in humans and its incidence is rising. These tumours can evolve as diseases of poor prognosis, and therefore it is important to identify new markers to better predict its clinical evolution.OBJECTIVES:We aimed to identify the expression pattern of microRNAs (miRNAs or miRs) at different stages of skin cancer progression in a panel of murine skin cancer cell lines. Owing to the increasing importance of miRNAs in the pathogenesis of cancer, we considered the possibility that miRNAs could help to define the prognosis of CSCC and aimed to evaluate the potential use of miR-203 and miR-205 as biomarkers of prognosis in human tumours.METHODS:Seventy-nine human primary CSCCs were collected at the University Hospital of Salamanca in Spain. We identified differential miRNA expression patterns at different stages of CSCC progression in a well-established panel of murine skin cancer cell lines, and then selected miR-205 and miR-203 to evaluate their association with the clinical prognosis and evolution of human CSCC.RESULTS:miR-205 was expressed in tumours with pathological features recognized as indicators of poor prognosis such as desmoplasia, perineural invasion and infiltrative growth pattern. miR-205 was mainly expressed in undifferentiated areas and in the invasion front, and was associated with both local recurrence and the development of general clinical events of poor evolution. miR-205 expression was an independent variable selected to predict events of poor clinical evolution using the multinomial logistic regression model described in this study. In contrast, miR-203 was mainly expressed in tumours exhibiting the characteristics associated with a good prognosis, was mainly present in well-differentiated zones, and rarely expressed in the invasion front. Therefore, the expression and associations of miR-205 and miR-203 were mostly mutually exclusive. Finally, using a logistic biplot we identified three clusters of patients with differential prognosis based on miR-203 and miR-205 expression, and pathological tumour features.CONCLUSIONS:miR-205 and miR-203 tended to exhibit mutually exclusive expression patterns in human CSCC. This work highlights the utility of miR-205 and miR-203 as prognostic markers in CSCC.

A Panel Of Mirnas As Prognostic Indicators For Clinical Outcome Of Skin Cutaneous Melanoma

Identification of a Five-Mirna Signature Predicting Survival in Cutaneous Melanoma Cancer Patients.

New Prognostic Biomarkers and Drug Targets for Skin Cutaneous Melanoma Via Comprehensive Bioinformatic Analysis and Validation

Micro RNA (mir)‐203 and Mir‐205 Expression Patterns Identify Subgroups of Prognosis in Cutaneous Squamous Cell Carcinoma

Bioinformatics Analysis Identifies MicroRNAs and Target Genes Associated with Prognosis in Patients with Melanoma

Integrated Analysis to Reveal Potential Therapeutic Targets and Prognostic Biomarkers of Skin Cutaneous Melanoma

Identification of Metastasis-Associated MicroRNAs in Metastatic Melanoma by Mirna Expression Profile and Experimental Validation

Establishing a Three-Mirna Signature As a Prognostic Model for Colorectal Cancer Through Bioinformatics Analysis.

A Panel Of 13-Mirna Signature As A Potential Biomarker For Predicting Survival In Pancreatic Cancer

Association of miR-146a-5p and miR-21-5p with Prognostic Features in Melanomas

Mir-100-5p is a Novel Biomarker That Suppresses the Proliferation, Migration, and Invasion in Skin Cutaneous Melanoma.

A Novel Prognostic Model Based on Three Clinic-Related Mirnas for Prostate Cancer.

Novel MicroRNA Biomarkers, <i>miR-142-5p</i>, <i>miR-550a</i>, <i>miR-1826</i>, and <i>miR-1201</i>, Were Identified for Primary Melanoma

Plasma Mir-324-3p and Mir-1285 As Diagnostic and Prognostic Biomarkers for Early Stage Lung Squamous Cell Carcinoma

Characterization of coagulation-related gene signature to predict prognosis and tumor immune microenvironment in skin cutaneous melanoma

Bioinformatics Analysis of a Prognostic Mirna Signature and Potential Key Genes in Pancreatic Cancer

Identification of Immune-Related Biomarkers Associated with Tumorigenesis and Prognosis in Skin Cutaneous Melanoma.

Diagnostic and Prognostic Implications of a Serum Mirna Panel in Oesophageal Squamous Cell Carcinoma.

Identification of miRNA-mRNA Regulatory Network and Construction of Prognostic Signature in Cervical Cancer

Circulating miR-221 expression level and prognosis of cutaneous malignant melanoma.

Prognostic Significance of miRNA Subtypes in Melanoma: A Survival Analysis and Correlation with Treatment Response Across Patient Stages